Anika Therapeutics Inc (ANIK)

R&D Expenses

$7.34M

Quarterly · Period ending: · USD

ANIK logo

ANIK R&D Expenses

Latest reported$7.34M
ANIK Quarterly R&D Expenses ($0.00 → $7.34M)
High-resolution chart · PNG

ANIK r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Anika Therapeutics Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
7,341,000
6,713,000
6,452,000
6,946,000
6,313,000
6,059,000
2,738,000
7,244,000
6,682,000
8,164,000
7,585,000
7,791,000
8,914,000
8,400,000
7,749,000
7,301,000
6,975,000
6,157,000
6,000,000
7,673,000
7,293,000
6,361,000
7,632,000
5,217,000
4,532,000
6,050,000
4,084,000
4,158,000
4,165,000
4,258,000
4,064,000
4,232,000
4,733,000
5,161,000
4,266,000
5,842,000
4,449,000
4,230,000
2,959,000
2,822,000
2,792,000
2,159,000
3,016,000
2,061,689
1,812,320
2,097,762
1,983,412
1,999,867
1,873,158
2,287,715
2,029,901
1,618,012
1,829,052
1,582,910
1,339,677
1,217,086
1,298,170
1,533,103
1,530,762
1,531,355
1,574,155
1,532,664
1,387,713
1,774,623
1,836,653
1,875,644
1,318,849
2,382,146
2,286,229
2,194,308
2,444,529
1,801,561
1,644,619
1,508,340
1,395,402
1,125,826
996,051
847,341
504,477
905,289
1,129,877
1,076,792
1,093,000
979,000
1,461,000
1,199,000
1,067,000
988,000
1,125,000
907,000
656,000
482,000
648,000
809,000
788,293
999,137
1,050,426
1,089,874
1,184,947
826,378
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.